scholarly journals Using the Starr Frame and Da Vinci surgery system for pelvic fracture and sacral nerve injury

Author(s):  
Ye Peng ◽  
Wei Zhang ◽  
Gongzi Zhang ◽  
Xiang Wang ◽  
Shuwei Zhang ◽  
...  
2014 ◽  
Vol 13 (3) ◽  
pp. 16
Author(s):  
S. Khorrami ◽  
Y. Al Salhi ◽  
F. Annino ◽  
M. De Angelis
Keyword(s):  
Da Vinci ◽  

2019 ◽  
Vol 77 (6) ◽  
pp. 596-608 ◽  
Author(s):  
Payam Abrishami ◽  
Albert Boer ◽  
Klasien Horstman

This article investigates qualitatively the value profile of the da Vinci® surgical robot after almost two decades of extensive clinical use and research. We aimed to understand whether the swiftly growing body of published studies on robotic prostate surgery can now, that is, beyond an early stage, guide decisions on the acquisition, procurement, and public provision of this innovation. We explored both published studies and the perspectives of diverse stakeholders in the Netherlands. Both arenas represent conflicting, often polarised arguments on the (added) value of da Vinci surgery. What was unclear a decade ago due to lack of evidence is now unclear because of controversies about evidence. The article outlines controversial value issues and indicates the unlikelihood that awaiting more research — amid the mantra “further studies are needed” — will resolve the controversy. The study underscores multi-stakeholder deliberation to resolve controversies regarding the value of advanced medical innovations.


2014 ◽  
Vol 16 (4) ◽  
pp. 363-366
Author(s):  
Yosuke Hirasawa ◽  
Kunihiko Yoshioka ◽  
Ryo Iseki ◽  
Kazunori Namiki ◽  
Masaaki Tachibana

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Soichiro Yoshida ◽  
Shohei Fukuda ◽  
Toshihiro Kanda ◽  
Naotaka Fukui ◽  
Kazutaka Saito ◽  
...  

2015 ◽  
Vol 22 (5) ◽  
pp. 520-521 ◽  
Author(s):  
Soichiro Yoshida ◽  
Naotaka Fukui ◽  
Kazutaka Saito ◽  
Yasuhisa Fujii ◽  
Yukio Kageyama ◽  
...  

2011 ◽  
Vol 70 (6) ◽  
pp. 1489-1494 ◽  
Author(s):  
Jun Yang ◽  
Gang Zheng ◽  
Zhendong Zhou ◽  
Wenli Guo

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Shuang Wu ◽  
Jialei Chen ◽  
Yun Yang ◽  
Wei Chen ◽  
Rong Luo ◽  
...  

Abstract Background This study aimed to evaluate the radiographic and clinical outcomes of anterior subcutaneous internal fixation (INFIX) with or without posterior fixation for the treatment of unstable pelvic fractures. Methods Intraoperative blood loss, operation time, and duration of hospital stay were recorded, and fracture union and postoperative complications were evaluated. The fracture reduction quality was evaluated using the Matta score, pelvic deformity index (PDI), and pubic symphyseal width (PSW). In addition, the functional recovery and general quality of life were evaluated using the Majeed score and the 12-Item Short-Form Survey (SF-12), respectively. Furthermore, sacral nerve injury was evaluated using the Gibbons classification. Results Twenty-seven patients (14 males and 13 females) with an average age of 37.4 years were followed up for a mean of 22 months. The average operation time, median intraoperative blood loss, and average duration of hospital stay were 129 ± 47 min, 100 mL, and 22 ± 13 days, respectively. All patients achieved bony union with an average union time of 13.3 weeks. Furthermore, the average PDI and PSW were 0.07 ± 0.04 vs. 0.04 ± 0.03 (P = 0.009) and 1.15 ± 1.36 vs. 0.54 ± 0.17 (P = 0.048) before and after the operation, respectively. In 78% of the patients, the Matta or Majeed scores were excellent or good. The SF-12 physical and mental health scores were 45.1 ± 10.2 and 53.2 ± 6.3, respectively. Furthermore, one superficial surgical site infection, one loosening of INFIX, one lateral femoral cutaneous nerve irritation, one femoral nerve injury, and two implant discomforts due to the bar were noted. Among five patients with sacral nerve injuries, four were asymptomatic, and one just had paresthesia at the last follow-up. Conclusion INFIX with or without sacroiliac screws can achieve satisfactory radiographic and functional outcomes in the treatment of unstable pelvic ring fractures. Trial registration ChiCTR2000038812. Registered 04 October 2020. Retrospectively registered.


2022 ◽  
Vol 12 (1) ◽  
pp. 52
Author(s):  
Kuang-I. Cheng ◽  
Jockey Tse ◽  
Tzu-Ying Li

In 2000, the da Vinci Surgery System was approved by the United States Food and Drug Administration for general laparoscopic surgery and it became the first commercially available robotic surgery system. The aim of this study was to identify the incidence of postoperative pulmonary complications (PPCs) in patients undergoing da Vinci surgery and to observe whether the incidence of PPCs was affected by the usage of Sugammadex. Sugammadex is a gamma-cyclodextrin that encapsulates and subsequently inactivates steroidal neuromuscular blocking agents. A retrospective study was conducted on patients who had undergone da Vinci surgery in a single medical center in southern Taiwan during the period from January 2018 to December 2018. We extracted data on patient characteristics, usage of Sugammadex and PPCs for analysis. Three hundred and thirty-three patients were enrolled in the final analysis. While the overall incidence of PPCs was 30.3% (101/333 patients), the incidence of PCC in patients who received Sugammadex (24.2%) was significantly lower than those without (37.3%) (p = 0.001). Risk factors that appeared to be closely associated with PCC included age, malignancy, hypertension, chronic kidney disease, blood loss amount and anemia. The use of Sugammadex decreased the risk of PPC. In order to enhance early recovery after da Vinci surgery, the use of Sugammadex to rapidly reverse muscle relaxants may be an appropriate choice.


2018 ◽  
Vol 61 (4) ◽  
pp. 514-519 ◽  
Author(s):  
George Melich ◽  
Ajit Pai ◽  
Ramy Shoela ◽  
Kunal Kochar ◽  
Supriya Patel ◽  
...  
Keyword(s):  
Da Vinci ◽  

Sign in / Sign up

Export Citation Format

Share Document